bpc 157 rat study Frontiers Regeneration or Risk? A Narrative

these were not completed in peer-reviewed form, and a Phase I safety study has been mentioned in the literature but its results were never published

Unlike traditional growth hormone therapy, AOD-9604 does not significantly increase insulin-like growth factor-1 (IGF-1) or disrupt normal hormone levels

These side effects are usually temporary and go away on their own

Peptides are protein-based compounds that break down when exposed to heat, light, and temperature swings, so a dedicated cold storage unit that holds a steady, monitored temperature is one of the simplest ways to protect a vials potency from the day it is reconstituted until the day it is used up

Personal Opinion: For stubborn elbow tendinopathy that has resisted other treatments, the BPC-157 and TB-500 combination represents a logical escalation